Level A Evidence
4 Treatment Options Available
Lung Cancer Treatment
Advanced Lung Cancer Care: Surgery, Radiation & Targeted Therapy
Lung cancer treatment requires a multidisciplinary approach combining surgery, radiation, and systemic therapy. Our partner cancer centers offer comprehensive care from early diagnosis through advanced treatment. China has over 80 proton/heavy ion therapy centers and leads in immunotherapy clinical trials access.
Condition Overview
Conditions We Treat
Non-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)Lung NodulesMediastinal TumorsMetastatic Lung Cancer
Core Technologies
VATS/Minimally invasive surgery | Proton/Heavy ion therapy | Immunotherapy (PD-1/PD-L1) | Targeted therapy (EGFR, ALK, ROS1) | MDT tumor board
ผู้สมัครที่เหมาะสม
- •Stage III lung cancer requiring multimodal therapy
- •Need for proton/heavy ion therapy
- •Access to immunotherapy clinical trials
- •Complex mediastinal involvement
- •Repeat biopsy for genomic profiling
High-volume centers with >2,000 lung cancer cases/year
พิจารณาทางเลือกในประเทศ
- •Early-stage (Stage I) with straightforward surgical plan
- •Standard chemotherapy protocols without complications
- •Cases with good local oncology team
- •Stable maintenance therapy phase
Stable cases where local hospital has thoracic surgery expertise
Evidence: Partner centers >2,000 lung cancer cases/year; 92% R0 resection for Stage I-II; proton therapy 5-year survival 85% for Stage I NSCLC.
Treatment Options
VATS Lobectomy (Minimally Invasive)
ศัลยกรรมเหมาะสำหรับ:Stage I-II NSCLC, peripheral lesions
เทคโนโลยี:Video-assisted thoracoscopic surgery, 3-4 port incisions
ข้อดี:Less pain, faster recovery, same oncologic outcome
5-7 daysFrom $8,000
>1,500 VATS lobectomies/year at top centersProton/Heavy Ion Therapy
รังสีบำบัดเหมาะสำหรับ:Stage I-III, central tumors, post-operative
เทคโนโลยี:Pencil beam scanning, intensity-modulated proton therapy
ข้อดี:Precise dose delivery, spares healthy tissue, fewer side effects
4-6 weeks dailyFrom $40,000
30+ proton centers, 10,000+ patients treatedImmunotherapy (PD-1/PD-L1 Inhibitors)
การรักษาทั้งระบบเหมาะสำหรับ:Stage III-IV, high PD-L1 expression, post-chemo
เทคโนโลยี:Pembrolizumab, nivolumab, sintilimab, camrelizumab
ข้อดี:Durable responses, 20-40% 5-year survival in responders
Every 2-3 weeks, ongoingFrom $300/dose
Access to approved drugs and clinical trialsTargeted Therapy
การรักษาทั้งระบบเหมาะสำหรับ:EGFR, ALK, ROS1, MET, RET mutations
เทคโนโลยี:Osimertinib, alectinib, crizotinib, generics available
ข้อดี:High response rates (60-80%), oral administration
Daily, ongoingFrom $200/month
Comprehensive genomic testing availableคู่มือและบทความที่เกี่ยวข้อง
การเปรียบเทียบค่าใช้จ่าย
Lung Cancer Treatment Package (Surgery + Adjuvant Therapy)
US Hospital$120,000
UK Private$90,000
MediLink China$35,000
Save 71% vs US • Includes: VATS lobectomy, 4 cycles chemotherapy, genetic testing, MDT consultations
ขั้นตอนการรักษา
1
Diagnosis & Staging• Week 1-2
- Day 1-2: PET-CT, brain MRI, bronchoscopy with EBUS
- Day 3-4: Biopsy with genomic profiling (EGFR, ALK, PD-L1)
- Day 5: MDT tumor board discussion
- Day 6-7: Treatment plan finalization
2
Primary Treatment• Week 2-8
- Surgery: VATS lobectomy or pneumonectomy
- Pathology review and staging confirmation
- Adjuvant chemotherapy (if indicated): 4 cycles
- Radiation therapy planning (if needed)
3
Follow-up & Surveillance• Years 1-5
- CT chest every 3-6 months (Year 1-2)
- PET-CT annually
- Tumor marker monitoring
- Remote consultation for any concerns
Clinical Outcomes
Stage I 5-Year Survival
85%+
after definitive treatment
R0 Resection Rate
92%
Stage I-II NSCLC
Post-op Complication
<8%
VATS lobectomy
Immunotherapy Response
35-40%
PD-L1 >50%
คำถามที่พบบ่อย
Is lung cancer treatment in China as advanced as in the US?
China has over 80 proton/heavy ion therapy centers and offers the same immunotherapy and targeted therapy drugs. Many Chinese cancer centers are JCI-accredited and participate in international clinical trials. 5-year survival rates for Stage I NSCLC are comparable to US data (85%+).
What genomic tests are available for lung cancer?
Comprehensive genomic profiling is available including EGFR, ALK, ROS1, BRAF, MET, RET, KRAS, NTRK, PD-L1. Results typically available within 7-10 days. Liquid biopsy (ctDNA) also available for cases where tissue biopsy is not feasible.
Can I access immunotherapy clinical trials in China?
Yes. China has one of the largest numbers of oncology clinical trials globally. Many trials offer access to novel immunotherapy combinations and next-generation targeted therapies not yet approved elsewhere.
How soon after surgery can I return home?
For VATS lobectomy: typically 7-10 days post-surgery. For complex cases requiring additional treatment: 3-4 weeks. We provide detailed post-operative care instructions and remote follow-up support.
What is the approximate lung cancer surgery China cost including surgery and adjuvant therapy?
Lung cancer surgery China cost for a typical package (VATS lobectomy plus 4 cycles adjuvant chemotherapy, genetic testing, MDT consultations) is from approximately $35,000, versus $120,000+ in the US—about 70% savings.
Ready to Learn More?
Get a personalized treatment plan from our oncology specialists within 48 hours.